Invivyd's Q4 2024 Pemgarda revenue hit $13.8 million, up 48% from Q3, with $69.3 million in year-end cash reserves. Get real-time earnings alerts before the market moves and access expert analysis ...
WALTHAM, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback